<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04490746</url>
  </required_header>
  <id_info>
    <org_study_id>ç ”2020-556</org_study_id>
    <nct_id>NCT04490746</nct_id>
  </id_info>
  <brief_title>Identifcation of Biomarkers for Active Pulmonary Tuberculosis</brief_title>
  <official_title>Identifcation of Biomarkers for Active Pulmonary Tuberculosis Using a Metabolomics Approach: a Prospective Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This experiment is designed to analyze the metabolites in body fluids from patients with&#xD;
      active tuberculosis and latent tuberculosis infection also with health volunteer, then&#xD;
      combine the metabolic product features with clinical characteristics, to develop a kind of&#xD;
      metabolites targets to evaluate the progress in tuberculosis, thus provide a basis for&#xD;
      further utilization of humoral metabolites in the diagnosis of tuberculosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>metabolic product</measure>
    <time_frame>24 hours after sampling</time_frame>
    <description>features up-regulated or down-regulated</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Tuberculosis</condition>
  <condition>Diagnosis</condition>
  <arm_group>
    <arm_group_label>active</arm_group_label>
    <description>patients with active tuberculosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>latent</arm_group_label>
    <description>patients with latent tuberculosis infection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>negtive control</arm_group_label>
    <description>healthy volunteers</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>with no intervention, Collect samples</intervention_name>
    <description>only with observation,there is no need to intervene</description>
    <arm_group_label>active</arm_group_label>
    <arm_group_label>latent</arm_group_label>
    <arm_group_label>negtive control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with active tuberculosis and latent tuberculosis infection&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with active tuberculosis and latent tuberculosis infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  have other serious health problems&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pintong Huang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yajing Liu</last_name>
    <phone>18358152521</phone>
    <email>liuyajingyyyyy@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>0571</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 26, 2020</study_first_submitted>
  <study_first_submitted_qc>July 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2020</study_first_posted>
  <last_update_submitted>July 26, 2020</last_update_submitted>
  <last_update_submitted_qc>July 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Tuberculosis, Pulmonary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>individual participant data (IPD) can be shared after the main unit publish articals</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>by request</ipd_time_frame>
    <ipd_access_criteria>by request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

